We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > marketing application

News List

Weekly Pharma News Review | PharmaSources.com (May.6th to May.15th) PharmaSources.com
May 18, 2022
The most encouraging news this week is that the international, multicenter, Phase III clinical trials of Hengrui's PD-1 combination therapy for liver cancer have been announced to be successful.
Weekly Pharma News Review | PharmaSources.com （April.18th - 22ed） PharmaSources.com
April 27, 2022
The pharma news review of this week totally covers 22 pieces of news in 3 sections, including drug review, R&D, and business.
Good News in the Chinese Diabetes Field and Several Original Research Drugs Underway PharmaSources/Dopine
May 25, 2021
Glad tidings came recently in terms of supervision of two domestic diabetes drugs. Semaglutide, Novo Nordisk's blockbuster hypoglycemic drug, advanced to the administrative approval stage (acceptance number: JXSS2000005/6) on April 20.
EMA Validates Marketing Application for Filgotinib for Rheumatoid Arthritis americanpharmaceuticalreview
August 19, 2019
Gilead Sciences and Galapagos announced that the Marketing Authorization Application (MAA) for filgotinib, an investigational, oral, selective JAK1 inhibitor, for the treatment of adults with rheumatoid arthritis (RA) has been validated and ...